Lusutrombopag is an orally bioavailable thrombopoietin (TPO) receptor agonist. Lusutrombopag acts selectively on the human TPO receptor and activates signal transduction pathways that promote the proliferation and differentiation of bone marrow cells into megakaryocytes, thereby increasing platelet levels.
Molecular Weight:
591.55
Purity:
>98.0%
CAS Number:
[1110766-97-6]
Formula:
C29H32Cl2N2O5S
Target:
Thrombopoietin/Thrombin
* VAT and and shipping costs not included. Errors and price changes excepted